skip to content

Centre for Pathogen Evolution

 

For queries relating to publications, please contact: CPEadmin@zoo.cam.ac.uk

  • Mühlemann, B., Wilks, S. H., Baracco, L., Bekliz, M., Carreño, J. M., Corman, V. M., Davis-Gardner, M. E., Dejnirattisai, W., Diamond, M. S., Douek, D. C., Drosten, C., Eckerle, I., Edara, V.-V., Ellis, M., Fouchier, R. A. M., Frieman, M., Godbole, S., Haagmans, B., Halfmann, P. J., … Smith, D. J. (2024). Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays. Science Translational Medicine, 16(747), eadl1722. doi:10.1126/scitranslmed.adl1722

  • Gupta, R., Abdullahi, A., Onyemata, J., Turner, S., Edun, M., Kramner, A., Sievers, B., Cheng, M., Morse, R., Abdullahi, H., Okpokoro, E., Osawe, S., Kida, I., Aliyu, S., Meng, B., Döffinger, R., Smith, D., & Abimuku, A. (2024). Immune imprinting revealed by SARS-CoV-2 Omicron infection prior to vaccination. doi:10.21203/rs.3.rs-4186317/v1

  • Turner, S., Amirthalingam, G., Bailey, D., Barouch, D. H., Bewley, K. R., Brown, K., Cao, Y., Chan, Y.-W., Charlton, S., Consortium, D., Coombes, N. S., Hallis, B., Ho, D. D., Jian, F., Lasrado, N., Lassaunière, R., Liu, L., Montefiori, D. C., Moss, P., … Smith, D. J. (2024). Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86 (p. 2024.03.27.586820). bioRxiv. doi:10.1101/2024.03.27.586820
  •  
  • Fan, S., Kong, H., Babujee, L., Presler, R., Jester, P., Burke, D., Pattinson, D., Barr, I., Smith, D., Neumann, G., & Kawaoka, Y. (2024). Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera. eBioMedicine, 101. doi:10.1016/j.ebiom.2024.105013
  •  
  • Escalera, A., Laporte, M., Turner, S., Karakus, U., Gonzalez-Reiche, A. S., van de Guchte, A., Farrugia, K., Khalil, Z., van Bakel, H., Smith, D., García-Sastre, A., & Aydillo, T. (2024). The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity. Emerging Microbes & Infections, 13(1), 2297553. doi:10.1080/22221751.2023.2297553